Skip to search.
 FTSE 100 Down 2.44%

Abbott Laboratories (ABT)

-NYSE
43.07 Down 1.07(2.42%) 4 Sep 21:00
|After Hours: : 43.08 Up 0.01 (0.02%) 5 Sep 00:27
Add to Portfolio
Prev Close:44.14
Open:43.50
Bid:43.06 x 100
Ask:43.20 x 100
1y Target Est:55.23
Beta:1.31451
Earnings Date:20 Oct - 26 Oct (Est.)
Day's Range:42.72 - 43.71
52wk Range:39.28 - 51.74
Volume:7,057,333
Avg Vol (3m):5,946,710
Market Cap:64.19b
P/E (ttm):14.47
EPS (ttm):2.98
Div & Yield:0.96 (2.20%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ABT at this time.

Comparison

Symbol% ChgMkt Cap
ABTDown 2.42%64.19b

Key Statistics

Forward P/E (1 yr):17.80
P/S (ttm):3.21
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :2.17
Quarterly EPS Est (Sep-15) :0.54
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback